Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Menopause can accelerate age-related weight gain, increasing a woman’s odds of becoming overweight or obese, researchers said ...

Future GLP-1 gene therapy could enable long-term hormone production, with Fractyl Health and others planning human trials in 2024.

Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One ...

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

As of 2021–2022, approximately 74% of U.S. adults aged 20 and older were classified as overweight or obese, with 42.1% meeting criteria for obesity alone, according to the Centers for Disease Control ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

Credit: Getty Images By reinforcing the essential role of exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and improves functional health.

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...